Mutations in EZH2, most notably the Y646F hotspot substitution in the SET domain, enhance its methyltransferase activity, leading to increased global H3K27me3 levels and repression of tumor suppressor genes [2, 3, 5]. This evidence concerns the gene EZH2 and neoplasm.